Mayank portfolio

1

My name is Mayank ,i am 28 year old, i start investing in 2019 before covid with small amount just for exploring stock market . In covid I saw my small portfolio 60% down and then recovery back from 2021 i started take investing seriously make many mistakes and learn from them, in the end i went to go for technical and fundamental together . i learn many things from ishmohit @Worldlywiseinvestors and hitesh Sir @hitesh2710 :pray::pray:, My process of investing is go through business and fundamental and then for valuation use a peg ratio of 1.5 for B to B and 2 for B to C, then get entry exit are based on technical .I took peg ratio on expected future earning for 2 to 3 years.
currently i am holding

S.NO STOCK BSE/NSE PRICE PE ESTIMATED GROWTH 3Y PEG PORTFOLIO %
1 SENCO SENCO 863.65 35 22 1.59 15.3
2 NUVAMA BOM:543988 4876.05 27 21 1.29 14.4
3 PRICOL PRICOLLTD 442.95 41.82 30 1.39 12
4 SUPRIYA LIFE SCIENCE SUPRIYA 378.05 25.35 25 1.01 9.9
5 TANLA TANLA 896.35 22.01 18 1.22 8.7
6 GARWARE HI TECH GRWRHITECH 1675 20.66 16 1.29 8.4
7 SAMHI SAMHI 199.3 #N/A 20 #N/A 7.3
8 EPIGRAL EPIGRAL 1286.75 27.31 18 1.52 6.9
9 ADF FOODS ADFFOODS 233.75 33.9 20 1.70 6.5
10 NEULAND LAB NEULANDLAB 6227.4 25.32 20 1.27 5.4
11 GRAVITA GRAVITA 944.15 26.95 20 1.35 5
TOTAL 26.52666667 21.90909091 1.24 100
  1. Senco gold - expecting good growth by adding new stores in both fofo and coco based store , stud ratio is also improving, valuation is not so expensive.

2.Nuvama- good growth in wealth management business over sector is doing good adding RMs spending on tech overall decent business with decent valuation.

3.Pricol - good business profit can be doubled in 2-3 years. getting in 4 wheeler market getting orders for EVs to. valuation is expensive but growth is visible.

4.Supriya life science - betting on management and on reasonable valuation, I am not expert in pharm holding it on the bases of technical . near term growth trigger are also good.

5.Tanla - betting on platform business . I think platform business have great potential but need some time to do so. it valuation is decent just waiting for growth.

6.Garware hi tech - Betting on their B to C brand going good in hard time where BOPET company are going in a losses.

7.Samhi hotel - hotel industry is going through tailwind as it has long dated cycle i am betting on Samhi hotel, they are mostly in T1 citys with good brand where supply is restricted. operating leverage can kick in.

8.Eprigal - margin recovery and volume growth are the key triggers.

9.ADF foods - Management is trying for creating B to C brands guiding for 20 growth, ASHOKA brand is doing good . valuation is better then other FMCG company.

10.Neuland lab - good management growth is expected from fy 26. China +1 can also be a good growth trigger.

11.Gravita - recycling industry is growing with a good pace I looks to see growing in a future . Their margins are not cyclical like other .

I am ready to learn plz share your views on my portfolio

dic; invested and biased

3 Likes
2

Any reason you choose NUVAMA over anand rathi in wealth management space?

3

Because of valuation but also thick anand rathi is better business them nuvama

1 Like
4

Hi @mayank_raghuwanshi thanks for thinking that i am capable of commenting on your portfolio. But i am not. So just commenting on few stocks i came across in the past.

Nuvama is in my portfolio among the top holdings. So i am biased here, so no comments.

Pricol i sold few days back. I have taken exit multiple at 30pe, based on that i get 13 to 14% annualised return. Good enough but as i am 50% in debt i need to gun for slightly higher return. However, i can re enter stock any time. Next quarter will be good so please dont follow me.

Tanla i have not done enough work. I was not much comfortable with management. Or let me say i had not much reason to buy stock. Bulk sms related product does not sound too exciting to me.

Garware i sold due to historical governance question and related party transcation with promoter owned subsidiary. I can re enter but shall never be among top holdings.

I have no idea on rest all.
Thanks for your trust in me.

Disclaimer: I am not a financial advisor and nor a SEBI registered Analyst. The content shared here is only for learning purpose. All the names mentioned here are for example purpose. I may buy more, exit or partly sell the stock/bonds without any prior intimation . Also note that I recently joined a investment advisory firm. My portfolio is not a recommendation for anyone. Some of these stocks might be in clients portfolio as well so please be aware of vested interest.

1 Like
5

Thanks sir for sharing your views.

6

portfolio as on 1-6-24

STOCK ESTIMATED GROWTH 2Y PEG PORTFOLIO %
1 GARWARE HI TECH 20 1.04 9.4
2 ADF FOODS 20 1.56 6.9
3 NUVAMA 21 1.29 14.9
4 SENCO 22 1.59 15.5
5 PRICOL 30 1.26 11.6
6 SUPRIYA LIFE SCIENCE 25 0.97 9.5
7 TANLA 18 1.26 9
8 SAMHI 20 #N/A 6
9 GRAVITA 20 1.53 5.7
10 NEULAND LAB 25 1.04 5.3
11 ALL E TECH 22 1.11 6.2
TOTAL 22 1.23 100
1 Like
7
SR.NO COMPANY ALLOCATION %
1 GARWARE HI TECH 10.3
2 ADF FOODS 8.1
3 NUVAMA 12.1
4 SENCO 15.9
5 PRICOL 10.8
6 SUPRIYA LIFE SCIENCE 10.9
7 SAMHI 6.5
8 GRAVITA 6.6
9 NEULAND LAB 6
10 ALL E TECH 6.2
11 PRIVI SPECILITY 3
12 DMCC 3.5
TOTAL 100

Made some changes sold tanla due to some of their past issue and add chemical company DMCC,PRIVI looking good for long term.

Invested:No recommendation

1 Like
8
S.NO STOCK PORTFOLIO %
1 NUVAMA 13.9
2 SENCO 12.8
3 GARWARE HI TECH 10.4
4 PRICOL 9.6
5 SUPRIYA LIFE SCIENCE 9.4
6 ALL E TECH 7.5
7 NEULAND LAB 7.3
8 ADF FOODS 6.6
9 GRAVITA 6.3
10 PRIVI SPECILITY 6.3
11 ORIENTAL A 4.9
12 DMCC 4.8
TOTAL 100

recently change Samhi hotel for Oriental aromatics I am bullish on chemical company as their margin are impacted and can do better from now .Techinal are showing the same.

9
STOCK PORTFOLIO %
GARWARE HI TECH 12.2
KRSNAA 5.3
NUVAMA 11.8
SENCO 13.1
PRICOL 8
SUPRIYA LIFE SCIENCE 12
ORIENTAL A 4.8
WOCKHARD 5.5
NEULAND LAB 8.3
ALL E TECH 8.3
PRIVI SPECILITY 5
DEEPAK FERTILIZER 5.6
TOTAL 100
Made some change sold Gravita,Dmcc and Adf food
Added Deepak fertilizer,Krsnaa,Wockhard.
10

you have exited from SAMHI before the turn around story plays out why is that ?

11

Any reason behind the exit from Epigral? Because their capex story is getting live one after the other and they have started posting food numbers…

12

it is not fulfilling my technical criteria, i try to look my portfolio as i have limited capital for me we are in a bull market and i try to maximize my portfolio returns. i am tracking samhi closely and can take position again.

13

i cant understand there ebidta margins and how they can sustain it. this is my view plz dont go for it.

14
15

Same reason here. I bought Anand Rathi at 1300 and sold at 2800. Put all that money in Nuvama at 3k levels. Rathi is v good but valuations are really stretched. One advantage of Rathi is their 0 debt. Really helps the valuation

1 Like
16
S.NO STOCK PORTFOLIO %
1 GARWARE HI TECH 14.1
2 KRSNAA 5.7
3 NUVAMA 11.7
4 SENCO 15.3
5 PRICOL 7.6
6 SUPRIYA LIFE SCIENCE 7.2
7 ORIENTAL A 4.6
8 LAURAS LAB 6.1
9 NEULAND LAB 6.2
10 THYROCARE TECH 4.7
11 PRIVI SPECILITY 5.7
12 DEEPAK FERTILIZER 5.6
13 JUBLANT PHARMOVA 5.6
TOTAL 100
SECTOR ALLOCATION%
MISCELLANEOUS 14.1
DIAGNOSTIC 10.4
WEALTH MANAGEMENT 11.7
RETAIL 15.3
AUTO ANCILLARY 7.6
CHEMICAL 15.9
PHARMA 25.1
TOTAL 100

Blockquote

17

added Thyrocare and exited from All e tech and wockhard.
Thyrocare- margin expection B2C business want to add krsnaa but due to its B2G dependence added thryocare.
All e tech is performing well but due to its current runup value went up and some how i want stay away from SME space for now.going to track it in future.

Wockhard exited due to the probablity of success in molecule is not very high
and i dont want to take that risk when i have better options.

cut some holding from supriya , neuland and added jubilant pharmova, lauras .On pharma i am trying to improve my understanding taking basket approach in it.

18

Current i am looking for some company like edelweiss financial services demerger for there alternate asset management business.
apollo pipes management is guiding for good growth and expending ebidta margin started look for it.
maharashtra seamless looking at great valutaion but waiting for next quater to see if they can improve their ebidta margin.

2 Likes
19
COMPANY PORTFOLIO %
GARWARE HI TECH 13.8
KRSNAA 5.5
NUVAMA 11.9
SENCO 13.2
SUPRIYA LIFE SCIENCE 7.3
ORIENTAL A 5.6
LAURAS LAB 5.8
NEULAND LAB 6
THYROCARE TECH 5.7
PRIVI SPECILITY 6.7
DEEPAK FERTILIZER 6.7
JUBLANT PHARMOVA 6
Edelweiss Financial Services 5.9
TOTAL 100

Currently my portfolio is down 7.74% from all time high for me its good because i am holding only mid and small caps. recently i made some changes sold pricol and purchased edelweiss financial services i consider edelweiss for is Alternative
Asset Mgt business which can go through demerger.

1 Like
20

Current quaterly result are going good for my portfolio companies.

image
image1080×1046 64.7 KB

company is generating good cash flow and acquiring new business for inorganic growth. its NABL Accredited labs is increasing my confidence in it.growth guidence is remain in midteen but profit growth and cash flow are moving it more.